Abstract
Withdrawal The authors have withdrawn this manuscript because there are increased rates of SARS- CoV-2 cases in the areas that we originally analyzed in this study. New analyses in the context of the third surge in the United States are therefore needed and will be undertaken directly in conjunction with the creators of the publicly-available databases on cases, hospitalizations, testing rates. Etc. We will be performing this in conjunction with machine learning experts at UCSF. Therefore, the authors do not wish this work to be cited as reference for the project. We hope to have an updated analysis using data from the 2nd and now 3rd wave of SARS-CoV-2 in this country soon. If you have any questions, please contact the corresponding author.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Grant: NIAID/NIH R01AI158013 - Monica Gandhi
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Exemption: de-identified publicly available data
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interests: The authors have no financial conflicts of interest to report
The authors have withdrawn this manuscript because there are increased rates of SARS-CoV-2 cases in the areas that we originally analyzed in this study. New analyses in the context of the third surge in the United States are therefore needed and will be undertaken directly in conjunction with the creators of the publicly-available databases on cases, hospitalizations, testing rates. Etc. We will be performing this in conjunction with machine learning experts at UCSF. Therefore, the authors do not wish this work to be cited as reference for the project. We hope to have an updated analysis using data from the 2nd and now 3rd wave of SARS-CoV-2 in this country soon. If you have any questions, please contact the corresponding author.
Data Availability
Publicly available de-identified data was obtained from the Delphi COVID-19 Surveillance Project dataset, open-sourced COVID-19 Tracking Project and SafeGraph COVID-19 Data Consortium
https://www.census.gov/programs-surveys/popest/technical-documentation/file-layouts.html
https://cmu-delphi.github.io/delphi-epidata/api/covidcast.html
https://covidtracking.com/about
https://www.safegraph.com/covid-19-data-consortium
https://bfi.uchicago.edu/working-paper/tracking-mask-mandates-during-the-covid-19-pandemic
